Navigation Links
Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)
Date:2/11/2009

QUEBEC, Feb. 11 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today the filing of a patent application for the detection and treatment of a physiological disorder that most likely leads to sudden unexplainable death in epileptic patients during seizure.

Victhom has recently filed a patent application relating to a method and device aimed at preventing sudden unexpected death in epilepsy (SUDEP) using its neuromodulation platform.

Epilepsy is the most common neurological disorder, affecting about 1% of the population worldwide. Current treatments that aim at treating seizures, include neuromodulation devices for stimulation of the vagus nerve by Cyberonics and a deep brain stimulation product, Medtronic's Intercept(TM) Epilepsy Control System, which is currently in clinical trials. "The death rate among epileptics is about three times that of age-matched cohorts. This statistic may be explained by consequences of epilepsy, but in a surprising number of cases, there is no obvious cause of death", said Mr. Nader Kameli, Chief Operating Officer of Victhom's Neurobionix division. Sudden death from unknown causes occurs in epileptics at a rate 24 times that of the general population. In patients with severe, refractory epilepsy, SUDEP may account for 50% of all deaths. While there is no toxicological or anatomical explanation for SUDEP, evidence suggests a respiratory failure during seizure.

Research has revealed that SUDEP could be avoided by preventing and/or treating both apnea and seizure, ensuring normal recovery from either or both events. The monitoring by our technology of multiple physiological indicators predisposing to SUDEP, like apnea and seizure activity, could be used, in combination with the treatment of seizures, to detect the need for and then apply a treatment for SUDEP. "We believe that our ability to detect and treat apnea in a timely fashion by using our neuromodulation platform could prove to be lifesaving for these patients. With this add-on therapy, we believe existing devices would not only be able to treat seizures but also prevent SUDEP that would result from respiratory dysfunction of failure", said Mr. Kameli. He further said: "The body of knowledge in post mortem analysis of these deaths suggests that abnormal respiratory patterns during seizure may have led to an unrecoverable condition possibly causing death".

As Victhom develops its scientific knowledge in the field of respiration and respiratory disorders, it continues to discover new and novel approaches to treat various conditions using its neuromodulation technology for detection and treatment. The current patent application is another sign of continued progress in this field.

With the recent CE Mark approval of the Neurostep(TM) System, Victhom is focused on the plans to introduce that product to the European market late 2009. Further developments in apnea and respiratory therapy will continue at the research level. Victhom plans in partnering with leaders in the field of epilepsy treatment to complete the development and introduction of this therapy to the market.

About Victhom Human Bionics

Victhom discovers, develops and manufactures bionic devices involved in the treatment of a variety of physical and physiological dysfunctions. Victhom's Neurobionix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix division develops biomechatronic products to support or replace peripheral limbs in what is known as the orthotics and prosthetics market.

Forward-Looking Statements

Some of the statements made herein may constitute forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause Victhom's actual results, performance or achievements to be materially different from those expressed or implied by any of Victhom's statements. Actual events or results may differ materially. We disclaim any intention, and assume no obligation, to update these forward-looking statements.


'/>"/>
SOURCE VICTHOM HUMAN BIONICS INC.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
2. Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
3. Victhom announces the completion of the second phase of the apnea therapy development
4. Victhom Announces Launch of Enhanced Company Website
5. Victhom to Participate in the OneMedPlace Finance Forum
6. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
7. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
8. Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results
9. Zeus Announces Product Name Changes
10. SciQuest Announces Strategic Alliance with Ceiba Solutions
11. On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is ... projects are designed, built and brought to market. , The Design Lab is ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
Breaking Biology Technology:
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
Breaking Biology News(10 mins):